Login to Your Account



Search

Search results

Clinic Roundup

No Abstract (BioWorld Today, BioWorld-Today-2006-07-19) ...

BioWorld Today - Staff - 2006-07-19 00:00 - 0 comments - 0 attachments

Clinic Roundup

No Abstract (BioWorld Today, BioWorld-Today-2010-02-25) ...

BioWorld Today - Staff - 2010-02-25 01:00 - 0 comments - 0 attachments

Clinic Roundup

• TapImmune Inc. , of Seattle, said an interim safety analysis of the first five breast cancer patients treated with HER2/neu Class II antigens did not show any serious adverse events, so treatment of the remaining 17 patients in the Phase I st ...

BioWorld Today - Staff - 2013-01-10 01:00 - 0 comments - 0 attachments

Clinic Roundup

No Abstract (BioWorld Today, BioWorld-Today-2007-10-16) ...

BioWorld Today - Staff - 2007-10-16 00:00 - 0 comments - 0 attachments

Clinic Roundup

• Cel-Sci Corp. , of Vienna, Va., said a second interim review of the safety data from its open-label, randomized, Phase III study of immunotherapy candidate Multikine (leukocyte interleukin, injection) was conducted, with the independent data monito ...

BioWorld Today - Staff - 2013-11-06 01:00 - 0 comments - 0 attachments

Clinic roundup

Brainstorm Cell Therapeutics Inc. , of New York and Petach Tikvah, Israel, said the FDA approved commencement of its phase II trial with Nurown in patients with amyotrophic lateral sclerosis (ALS). (BioWorld-Today-2014-04-29) ...

BioWorld Today - Staff - 2014-04-29 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Astellas Pharma US Inc ., of Northbrook, Ill., part of Astellas Pharma Inc., reported that efficacy and safety data of the isavuconazole invasive aspergillosis study (SECURE) were presented at the European Congress of Clinical Microbiology and Infect ...

BioWorld Today - Staff - 2014-05-15 00:00 - 0 comments - 0 attachments

Clinic roundup

Amgen, of Thousand Oaks, Calif., said data from the phase III LAPLACE-2 (LDL-C Assessment with PCSK9 MonoclonaL Antibody Inhibition Combined with Statin ThErapy-2) study were published in the Journal of the American Medical Association . ...

BioWorld Today - Staff - 2014-05-15 00:00 - 0 comments - 0 attachments

Clinic roundup

Basilea Pharmaceutica Ltd. , of Basel, Switzerland, reported that a phase III trial showed its antibiotic ceftobiprole to demonstrate more rapid clinical responses in hospital-acquired pneumonia and community-acquired pneumonia than a comparator regi ...

BioWorld Today - Staff - 2014-05-14 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Astrazeneca plc , of London, reported phase III data showing that the combination of saxagliptin/dapagliflozin, as a dual add-on therapy in adults with type 2 diabetes who were inadequately controlled on metformin, resulted in statistically significa ...

BioWorld Today - Staff - 2014-05-14 00:00 - 0 comments - 0 attachments